These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38761067)

  • 1. ARID1A IDR Targets EWS-FLI1 Condensates and Finetunes Chromatin Remodeling.
    Xue J; Lv S; Yu M; Pan Y; Li N; Xu X; Zhang Q; Peng M; Liu F; Sun X; Lao Y; Yao Y; Song J; Wu J; Li B
    Protein Cell; 2024 May; ():. PubMed ID: 38761067
    [No Abstract]   [Full Text] [Related]  

  • 2. EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.
    Selvanathan SP; Graham GT; Grego AR; Baker TM; Hogg JR; Simpson M; Batish M; Crompton B; Stegmaier K; Tomazou EM; Kovar H; Üren A; Toretsky JA
    Nucleic Acids Res; 2019 Oct; 47(18):9619-9636. PubMed ID: 31392992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.
    Siligan C; Ban J; Bachmaier R; Spahn L; Kreppel M; Schaefer KL; Poremba C; Aryee DN; Kovar H
    Oncogene; 2005 Apr; 24(15):2512-24. PubMed ID: 15735734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-molecule Imaging of EWS-FLI1 Condensates Assembling on DNA.
    Zuo L; Ding J; Qi Z
    J Vis Exp; 2021 Sep; (175):. PubMed ID: 34570101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.
    Riggi N; Knoechel B; Gillespie SM; Rheinbay E; Boulay G; Suvà ML; Rossetti NE; Boonseng WE; Oksuz O; Cook EB; Formey A; Patel A; Gymrek M; Thapar V; Deshpande V; Ting DT; Hornicek FJ; Nielsen GP; Stamenkovic I; Aryee MJ; Bernstein BE; Rivera MN
    Cancer Cell; 2014 Nov; 26(5):668-681. PubMed ID: 25453903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis.
    Sánchez-Molina S; Figuerola-Bou E; Blanco E; Sánchez-Jiménez M; Táboas P; Gómez S; Ballaré C; García-Domínguez DJ; Prada E; Hontecillas-Prieto L; M Carcaboso Á; Tirado ÓM; Hernández-Muñoz I; de Álava E; Lavarino C; Di Croce L; Mora J
    Sci Adv; 2020 Oct; 6(43):. PubMed ID: 33097530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner.
    Harlow ML; Chasse MH; Boguslawski EA; Sorensen KM; Gedminas JM; Kitchen-Goosen SM; Rothbart SB; Taslim C; Lessnick SL; Peck AS; Madaj ZB; Bowman MJ; Grohar PJ
    Clin Cancer Res; 2019 Jun; 25(11):3417-3429. PubMed ID: 30723142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slit2 signaling stimulates Ewing sarcoma growth.
    Suvarna K; Jayabal P; Ma X; Shiio Y
    Genes Cancer; 2022; 13():88-99. PubMed ID: 36533189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex.
    Mo J; Tan K; Dong Y; Lu W; Liu F; Mei Y; Huang H; Zhao K; Lv Z; Ye Y; Tang Y
    Oncogene; 2023 Jan; 42(1):11-25. PubMed ID: 36357572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential disruption of EWS-FLI1 binding by DNA-binding agents.
    Chen C; Wonsey DR; Lemieux ME; Kung AL
    PLoS One; 2013; 8(7):e69714. PubMed ID: 23894528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma.
    Katschnig AM; Kauer MO; Schwentner R; Tomazou EM; Mutz CN; Linder M; Sibilia M; Alonso J; Aryee DNT; Kovar H
    Oncogene; 2017 Oct; 36(43):5995-6005. PubMed ID: 28671673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage.
    Ban J; Siligan C; Kreppel M; Aryee D; Kovar H
    Adv Exp Med Biol; 2006; 587():41-52. PubMed ID: 17163154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity.
    Schlottmann S; Erkizan HV; Barber-Rotenberg JS; Knights C; Cheema A; Uren A; Avantaggiati ML; Toretsky JA
    Front Oncol; 2012; 2():107. PubMed ID: 22973553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
    Tang SW; Bilke S; Cao L; Murai J; Sousa FG; Yamade M; Rajapakse V; Varma S; Helman LJ; Khan J; Meltzer PS; Pommier Y
    Clin Cancer Res; 2015 Sep; 21(18):4184-93. PubMed ID: 25779942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.
    Toretsky JA; Erkizan V; Levenson A; Abaan OD; Parvin JD; Cripe TP; Rice AM; Lee SB; Uren A
    Cancer Res; 2006 Jun; 66(11):5574-81. PubMed ID: 16740692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
    He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
    Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.
    Minas TZ; Han J; Javaheri T; Hong SH; Schlederer M; Saygideğer-Kont Y; Çelik H; Mueller KM; Temel I; Özdemirli M; Kovar H; Erkizan HV; Toretsky J; Kenner L; Moriggl R; Üren A
    Oncotarget; 2015 Nov; 6(35):37678-94. PubMed ID: 26462019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities.
    Li M; Chen CW
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.
    Tsafou K; Katschnig AM; Radic-Sarikas B; Mutz CN; Iljin K; Schwentner R; Kauer MO; Mühlbacher K; Aryee DNT; Westergaard D; Haapa-Paananen S; Fey V; Superti-Furga G; Toretsky J; Brunak S; Kovar H
    Oncotarget; 2018 Jul; 9(57):31018-31031. PubMed ID: 30123424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.